[Amiodarone pulmonary toxicity].
Reĭngardene
D I
DI
Intensive Care Medicine Clinic, Institute of Cardiology, Kaunas University of Medicine.
Azaravichene
A P
AP
Korobkova
I Z
IZ
D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001344:Autopsy; D001706:Biopsy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006876:Hydrothorax / Q000139:chemically induced; D008168:Lung / Q000187:drug effects* / Q000473:pathology; D008171:Lung Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D008854:Microscopy, Electron; D010996:Pleural Effusion / Q000139:chemically induced; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D013902:Radiography, Thoracic; D011877:Radionuclide Imaging; D012129:Respiratory Function Tests; D012131:Respiratory Insufficiency / Q000139:chemically induced; D012307:Risk Factors; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011239:Prednisolone; D000638:Amiodarone
K voprosu amiodaronovogo toksicheskogo povrezhdeniia legkikh.